Tech Company Financing Transactions

Parse Biosciences Funding Round

Parse Biosciences secured a $41.5 million Series B funding round on 2/27/2022. Backers included Janus Henderson Investors, Marshall Wace and Bioeconomy Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

201 Elliott Ave. W 209
Seattle, WA 98119
USA

Phone

Undisclosed

Website

www.parsebiosciences.com

Email Address

[email protected]

Overview

Parse Biosciences is a company with the mission of accelerating progress in human health and scientific research. At the core of the company is a pioneering approach for single cell sequencing. Parse Biosciences is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Alex Rosenberg

        

Chief Technical Officer

Charlie Roco

        

Browse more venture capital transactions:

Prev: 2/26/2022: WSC Sports venture capital transaction
Next: 2/27/2022: Kallyope venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary